Tempest Therapeutics, Inc. (TPST) Misses Q2 EPS by 179c
Tweet
Share
E-mailGet Alerts TPST Hot Sheet
Join SI Premium – FREE
Tempest Therapeutics, Inc. (NASDAQ: TPST) reported Q2 EPS of ($2.07), $1.79 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Tempest Therapeutics, Inc. (TPST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Aurora targets 30,000 driverless trucks by 2030 at investor day
- Supermicro begins shipping Nvidia Vera Rubin NVL72 racks
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
